SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001214659-24-010797
Filing Date
2024-06-11
Accepted
2024-06-11 12:35:42
Documents
2
Period of Report
2024-06-03

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT marketforms-66282.html 3  
1 PRIMARY DOCUMENT marketforms-66282.xml 3 2293
2 POA DOCUMENT poa.htm EX-24 2973
  Complete submission text file 0001214659-24-010797.txt   6801
Mailing Address 30 TECHNOLOGY DRIVE WARREN NJ 07059
Business Address 30 TECHNOLOGY DRIVE WARREN NJ 07059 908-941-1900
Aquestive Therapeutics, Inc. (Issuer) CIK: 0001398733 (see all company filings)

IRS No.: 208623253 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O AQUESTIVE THERAPUETICS, INC. 30 TECHNOLOGY DRIVE WARREN NJ 07059
Business Address
Korczynski Sherry (Reporting) CIK: 0002026090 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38599 | Film No.: 241035147